GlassScriptPhysician profile
Anirban Basu
NPI 1245521491
$39,163.11
in general payments reported to CMS, 2019-2025
7 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $10K · 2021: $26K · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38,126.67 | 2019-2025 | |
| Stryker Corporation | $414.66 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $250.00 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $135.22 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.09 | 2019 | |
| Janssen Pharmaceuticals, INC | $76.89 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $39.58 | 2019-2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anirban Basu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.